Research location
Longueuil
Quebec, Canada
Advertisement
Research activity in Longueuil
Quebec, CanadaCureCurrent currently publishes aggregate city-level research activity for this location: 57 trials and 60 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Longueuil
57 linked trials · page 1 of 2Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic PhenotypeNCT07190222 · 2025-09-17 · 1 site observation
RECRUITING
Optimal Duration of Hormonal Therapy for Unfavorable Intermediate-risk Prostate Cancer Patients: 6 Versus 12 Months.NCT06855589 · 2025-03-01 · 1 site observation
NOT_YET_RECRUITING
A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and InflammationNCT05636176 · 2023-05-08 · 1 site observation
TERMINATED
Conventional Low Flow Oxygenation Versus High Flow Nasal Cannula in Hypercapnic Respiratory FailureNCT05497986 · 2022-10-01 · 1 site observation
UNKNOWN
Pelvic Nodes Ultra-Hypo vs Conventionally Fractionated IMRT With HDR Boost in Prostate Cancer.NCT05820633 · 2022-09-01 · 1 site observation
SUSPENDED
Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed Small-cell Lung Cancer (LAGOON)NCT05153239 · 2022-07-22 · 1 site observation
COMPLETED
Camu-Camu Prebiotic and Immune Checkpoint Inhibition in Patients With Non-small Cell Lung Cancer and MelanomaNCT05303493 · 2022-06-29 · 1 site observation
COMPLETED
Management of Oligoprogressive Castration Resistant Prostate Cancer (PCS X)NCT04070209 · 2020-10-19 · 1 site observation
ACTIVE_NOT_RECRUITING
DETERMINE-reduced - Dapagliflozin Effect on Exercise Capacity Using a 6-minute Walk Test in Patients With Heart Failure With Reduced Ejection FractionNCT03877237 · 2019-04-09 · 1 site observation
COMPLETED
DETERMINE-preserved - Dapagliflozin Effect on Exercise Capacity Using a 6-minute Walk Test in Patients With Heart Failure With Preserved Ejection FractionNCT03877224 · 2019-04-04 · 1 site observation
COMPLETED
Efficacy and Safety of BIIB033 (Opicinumab) as an Add-on Therapy to Disease-Modifying Therapies (DMTs) in Relapsing Multiple Sclerosis (MS)NCT03222973 · 2017-11-15 · 1 site observation
TERMINATED
SPI-2012 vs Pegfilgrastim in Management of Neutropenia in Breast Cancer Participants With Docetaxel and CyclophosphamideNCT02953340 · 2017-05-10 · 1 site observation
COMPLETED
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)NCT03071692 · 2017-03-23 · 1 site observation
TERMINATED
Management of Castration-Resistant Prostate Cancer with OligometastasesNCT02685397 · 2016-10-01 · 1 site observation
ACTIVE_NOT_RECRUITING
An Observational Study to Assess the Canagliflozin Treatment in Type 2 Diabetes Mellitus in a Usual Clinical Practice in CanadaNCT02688075 · 2015-11-13 · 1 site observation
COMPLETED
Predictors of the Long-term Functional Benefits of a Pulmonary Rehabilitation Program?NCT02528487 · 2015-05-01 · 1 site observation
SUSPENDED
Comparing the Efficacy of Tiotropium + Olodaterol (5/5 µg) Fixed Dose Combination (FDC) Over Tiotropium 5µg in Reducing Moderate to Severe Exacerbations in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease.NCT02296138 · 2015-01-13 · 1 site observation
COMPLETED
A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes MellitusNCT01991795 · 2014-02-10 · 1 site observation
COMPLETED
Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and Exacerbations in Moderate to Very Severe COPD Patients.NCT01966107 · 2013-10-16 · 1 site observation
COMPLETED
Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)NCT01897532 · 2013-07-10 · 1 site observation
COMPLETED
Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular EventsNCT01730534 · 2013-04-25 · 1 site observation
COMPLETED
A Study on The Potential of Aleglitazar to Reduce Cardiovascular Risk in Patients With Stable Cardiovascular Disease and Glucose AbnormalitiesNCT01715818 · 2012-12-01 · 1 site observation
COMPLETED
Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular DiseaseNCT01609582 · 2012-06-01 · 1 site observation
TERMINATED
Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 DiabetesNCT01481116 · 2012-01-01 · 1 site observation
TERMINATED
Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 DiabetesNCT01167881 · 2010-08-01 · 1 site observation
COMPLETED
BI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME).NCT01131676 · 2010-07-01 · 2 site observations
COMPLETED
Does Saxagliptin Reduce the Risk of Cardiovascular Events When Used Alone or Added to Other Diabetes MedicationsNCT01107886 · 2010-05-01 · 1 site observation
COMPLETED
Comparison of Tiotropium in the HandiHaler Versus the Respimat in Chronic Obstructive Pulmonary DiseaseNCT01126437 · 2010-05-01 · 1 site observation
COMPLETED
A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes MellitusNCT01042769 · 2010-02-01 · 1 site observation
COMPLETED
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart FailureNCT01035255 · 2009-12-01 · 1 site observation
TERMINATED
Canadian Study of Trandolapril on Blood Pressure in Hypertensive PatientsNCT01078584 · 2008-12-01 · 1 site observation
COMPLETED
A Diabetes Study to Treat A Population Previously Not at TargetNCT00747149 · 2008-05-01 · 1 site observation
COMPLETED
Tiotropium/Salmeterol Inhalation Powder in COPDNCT00668772 · 2008-04-15 · 1 site observation
TERMINATED
Efficacy and Safety of Dapagliflozin, Added to Therapy of Patients With Type 2 Diabetes With Inadequate Glycemic Control on InsulinNCT00673231 · 2008-04-01 · 1 site observation
COMPLETED
Moxifloxacin Versus Amoxicillin Clavulanic Acid in Treatment of Acute Exacerbation of Chronic BronchitisNCT00656747 · 2008-03-01 · 1 site observation
COMPLETED
Study Evaluating the Effect of IMA-638 in Subjects With Persistent AsthmaNCT00425061 · 2007-02-01 · 1 site observation
COMPLETED
A Pilot Study of BMS-512148 in Subjects With Type 2 DiabetesNCT00357370 · 2006-10-01 · 1 site observation
COMPLETED
Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone & Formoterol Administered Alone in Patients With AsthmaNCT00394199 · 2006-06-01 · 1 site observation
COMPLETED
Study In People With Type 2 DiabetesNCT00196989 · 2005-09-01 · 1 site observation
COMPLETED
G-PLUS (GALLANT, GALLEX and ARMOR - Post Treatment Follow-up Study)NCT00255645 · 2005-09-01 · 1 site observation
TERMINATED
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPDNCT00157339 · 2005-08-01 · 1 site observation
COMPLETED
Study Assessing Saxagliptin Treatment In Type 2 Diabetic Subjects Who Are Not Controlled With Metformin AloneNCT00121667 · 2005-08-01 · 1 site observation
COMPLETED
Study of Muraglitazar Versus Pioglitazone in Type 2 DiabetesNCT00106808 · 2005-08-01 · 1 site observation
COMPLETED
Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and ExerciseNCT00121641 · 2005-07-01 · 1 site observation
COMPLETED
GALLEX 6: Study to Evaluate the Safety and Tolerability of Tesaglitazar in Patients With Type 2 Diabetes MellitusNCT00226330 · 2005-03-01 · 1 site observation
TERMINATED
Study In Asthma ControlNCT00273026 · 2004-11-08 · 1 site observation
TERMINATED
Open Label Study Assessing Effectiveness Of Amlodipine/Atorvastatin In Subjects With Hypertension and DyslipidaemiaNCT00330785 · 2004-10-01 · 1 site observation
COMPLETED
Irbesartan Versus Placebo in Combination With Ramipril for Treatment of AlbuminuriaNCT00095290 · 2004-09-01 · 1 site observation
COMPLETED
Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin AloneNCT00095030 · 2004-02-01 · 1 site observation
COMPLETED
EVEREST: Efficacy of Vasopressin Antagonism in hEart failuRE: Outcome Study With TolvaptanNCT00071331 · 2003-09-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.